Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation

Phytochemistry

Volumn 71, Issue 2-3, 2010, Pages 243-248

  Avila, Liliana ^a   Perez, Moises ^b   Sanchez Duffhues, Gonzalo ^b   Hernández Galán, Rosario ^c   Muñoz, Eduardo ^b   Cabezas, Fabio ^d   Quiñones, Winston ^a   Torres, Fernando ^a   Echeverri, Fernando ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITY OF CÁDIZ   (Spain)

^d UNIVERSIDAD DEL CAUCA   (Colombia)

Author keywords

E. lactea; E. laurifolia; Euphorbiaceae; HIV; Latency; Reactivation therapy

Indexed keywords

ANTIVIRUS AGENT; DITERPENE; LATEX; PLANT EXTRACT;

ARTICLE; CD4+ T LYMPHOCYTE; CHEMISTRY; DRUG EFFECT; EUPHORBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LEUKEMIA CELL LINE; PHYSIOLOGY; PHYTOTHERAPY; VIRUS ACTIVATION; VIRUS LATENCY;

ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DITERPENES; EUPHORBIA; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LATEX; PHYTOTHERAPY; PLANT EXTRACTS; VIRUS ACTIVATION; VIRUS LATENCY;

EUPHORBIA; EUPHORBIA LACTEA; EUPHORBIA LAURIFOLIA; EUPHORBIACEAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73649139952     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2009.10.005     Document Type: Article

References (27)

1. Ahmed A., Couladis M., Mahmoud A., De Adams A., and Mabry T. Ingol diterpene ester from the latex of Euphorbia lactea. Fitoterapia 70 (1999) 140-143
2. Appendino G., Belloro E., Tron G.C., Jakupovic J., and Ballero M. Diterpenoids from Euphorbia pithyusa subsp. Cupanii. J. Nat. Prod. 62 (1999) 1399-1404
3. Blanco-Molina M., Tron G., Macho A., Lucena C., Calzado M., Muñoz E., and Appendino G. Ingenol esters induce apoptosis in Jurkat cells through an AP-1 and NF-UB independent pathway. Chem. Biol. 8 (2001) 767-778
4. Blankson J.N., Gallant J.E., Quinn T.C., Bartlett J.G., and Siliciano R.F. Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients. JAMA 288 (2002) 162-164
5. Daoubi M., Marquez N., Mazoir N., Benharref A., Hernandez-Galan R., Muñoz E., and Collado I. Isolation of new phenylacetylingol derivatives that reactivate HIV-1 latency and a novel spirotriterpenoid from Euphorbia officinarum latex. Bioorg. Med. Chem. 15 (2007) 4577-4584
6. Duarte N., Varga A., Cherepnev G., Radics R., Molnar J., and Ferreira M.-J.U. Apoptosis induction of P-glycoprotein mediated multidrugs resistance by new macrocyclic lathyrane-type diterpenes. Bioorg. Med. Chem. 15 (2007) 546-554
7. Ferreira A.M.V.D., Carvalho L.H.M., Carvalho M.J.M., Sequiera M.M., and Silva A.M.S. Jatrophane and lathyrane diterpenoids from Euphorbia hyberna L. Phytochemistry 61 (2002) 373-377
8. Gulakowski R.J., McMahon J.B., Buckheit Jr. R.W., Gustafson K.R., and Boyd M.R. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Res. 33 (1997) 87-97
9. Hamer D.H., Bocklandt S., McHugh L., Chun T.W., Blumberg P.M., Sigano D.M., and Marquez V.E. Rational design of drugs that induce human immunodeficiency virus replication. J. Virol. 77 (2003) 10227-10236
10. Hritz J., Ulicny J., Laaksonen A., Jancura D., and Miskovsky P. Molecular interaction model for the C1B domain of protein kinase C-γ in the complex with its activator phorbol-12-myristate-13-acetate in water solution and lipid bilayer. J. Med. Chem. 47 (2004) 6547-6555
11. Kazanietz M. Novel "nonkinase" phorbol ester receptors: the C1 domain connection. Mol. Pharmacol. 61 (2002) 759-767
12. In: Keeler R., and Tu A. (Eds). Toxicology of Plant and Fungal Compounds (1991), CRC Press, New York p. 665
13. Kheifets V., and Mochly-Rosen D. Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol. Res. 55 (2007) 467-476
14. Kulkosky J., and Bray S. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr. HIV Res. 4 (2006) 199-208
15. Kulkosky J., Culnan D.M., Roman J., Dornadula G., Schnell M., Boyd M.R., and Pomerantz R.J. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98 (2001) 3006-3015
16. Lu Z., Yang M., Zhang J., Chen G., Huang H., Guan S., Ma C., Liu X., and Guo D. Ingenane diterpenoids from Euphorbia esula. Phytochemistry 69 (2008) 812-819
17. Marquez N., Calzado M., Sanchez-Duffhues G., Perez M., Minassi A., Pagani A., Appendino G., Diaz L., Muñoz-Fernandez M.A., and Muñoz E. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation. Biochem. Pharmacol. 75 (2008) 1370-1380
18. Murillo J. Las Euphorbiaceae de Colombia. Biota Colombiana 5 (2004) 183-200
19. Persaud D., Zhou Y., Siliciano J.M., and Siliciano R.F. Latency in human immunodeficiency virus type 1 infection: no easy answers. J. Virol. 77 (2003) 1659-1665
20. Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., and Pomerantz R.J. The challenge of finding a cure for HIV infection. Science 323 (2009) 1304-1307
21. Touraine J., Hadden J., Touraine F., Hadden E., Estensen R., and Good R. Phorbol myristate acetate: a mitogen selective for a T-limphocyte subpopulation. J. Exp. Med. 145 (1977) 460-465
22. Trushin S.A., Bren G.D., Asin S., Pennington K.N., Paya C.V., and Badley A.D. Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta. J. Virol. 79 (2005) 9821-9830
23. Upadhyay R., and Hecker E. Diterpene esters of the irritant and cocarcinogenic latex of Euphorbia lactea. Phytochemistry 14 (1975) 2514-2515
24. Vigone A., Tron G.C., Surico D., Baj G., Appendino G., and Surico N. Ingenol derivatives inhibit proliferation and induce apoptosis in breast cancer cell lines. Eur. J. Gynaecol. Oncol. 26 (2005) 526-530
25. Warrilow D., Gardner J., Darnell G., Suhrbier A., and Harrich D. HIV type 1 inhibition by protein kinase C modulatory compounds. AIDS Res. Hum. Retroviruses 22 (2006) 854-864
26. Williams S.A., and Greene W.C. Regulation of HIV-1 latency by T-cell activation. Cytokine 39 (2007) 63-74
27. Williams S., Chen L., Kwon H., Fenard D., Bisgrove D., Verdin E., and Greene W. Prostratin antagonizes HIV latency by activating NF-kB. J. Biol. Chem. 279 (2004) 42008-42017